SSI Strategy to acquires NDA Group partner to form global life sciences consultancy
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
She will provide strategic advice and scientific leadership to support clients in clinical development, registration strategy, submission, early post-approval strategy
Subscribe To Our Newsletter & Stay Updated